PRESS RELEASE published on 05/25/2023 at 08:00, 2 years 11 months ago Biophytis Presented Positive Results of Phase 2-3 COVA Study At The American Thoracic Society International Conference
PRESS RELEASE published on 05/15/2023 at 08:00, 2 years 11 months ago Biophytis a demandé à l’EMA l’autorisation de lancer l’étude SARA-31 de phase 3 dans la sarcopénie
PRESS RELEASE published on 05/15/2023 at 08:00, 2 years 11 months ago Biophytis has filed with the EMA for authorization to initiate SARA-31 phase 3 study in sarcopenia
PRESS RELEASE published on 05/11/2023 at 08:00, 2 years 11 months ago Successful capital increase for Biophytis with €2.3 million raised
PRESS RELEASE published on 05/11/2023 at 08:00, 2 years 11 months ago Succès de l’augmentation de capital de Biophytis avec 2,3 millions d’euros levés
PRESS RELEASE published on 05/10/2023 at 19:05, 2 years 11 months ago Biophytis lance une levée de fonds d’environ 2 millions d’euros
PRESS RELEASE published on 05/10/2023 at 19:05, 2 years 11 months ago Biophytis launches a round of fundraising for approximately 2 million euros
PRESS RELEASE published on 05/09/2023 at 08:00, 2 years 11 months ago Biophytis has requested a pre-submission meeting with the EMA for the Marketing Authorisation of Sarconeos (BIO101) for the treatment of COVID-19
PRESS RELEASE published on 05/09/2023 at 08:00, 2 years 11 months ago Biophytis a requis auprès de l’EMA une réunion de pré-soumission d’Autorisation de Mise sur le Marché de Sarconeos (BIO101) dans le traitement de la COVID-19
PRESS RELEASE published on 05/02/2023 at 08:00, 3 years ago Biophytis annonce le renforcement de son équipe de Direction
Published on 05/09/2026 at 01:30, 3 hours 10 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 4 hours 40 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 20:38, 8 hours 2 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 9 hours 28 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 9 hours 38 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 9 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 9 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 9 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 9 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 9 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
